Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ethosuximide for Migraine Prevention in Veterans
NCT01122381Phase 2Terminated
- Sponsor
- United States Department of Veterans Affairs
- Start
- Dec 2011
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in migraine comparing Ethosuximide with Placebo (2 arms). Primary endpoint: Migraine Headache Days Per 4 Week Period. Started Dec 2011; status: terminated.
02
Drugs
ethosuximide
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01122381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01122381.